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conferred by EPO-TAT, suggesting that these 
two protective pathways worked in parallel.  
 
Conclusion: our study indicates parallel 
participation of AKT and ERK pathways in the 
protective mechanisms of EPO. 
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Purpose: Stroke is one of the leading causes 
of death worldwide. Protective agents that 
could diminish the injuries induced by cerebral 
ischemia/reperfusion (I/R) are crucial to 
alleviate the detrimental outcome of stroke. 
Retinal I/R also occurs in many ocular 
diseases and leads to neuronal death and 
therefore blindness. Lutein, a safe and potent 
antioxidant, is known to protect the retina in 
age-related macular degeneration. The aim of 
this study is to investigate the protective roles 
of lutein in cerebral and retinal I/R injury. 
 
Methods: Two-hour cerebral ischemia was 
induced by unilateral middle cerebral artery 
occlusion (MCAo) in mice. Either lutein 
(0.2mg/kg) or vehicle was given to mice 
intraperitoneally 1hr after MCAo and 1hr after 
reperfusion. Neurological deficits were 
evaluated at 22hr after reperfusion while 
survival rate was assessed daily until 7 days 
after reperfusion. Flash electroretinogram 
(flash ERG) was taken to assess retinal 
function. After sacrifice, mouse brains were cut 
into 2mm-thick coronal slices and stained with 
2% 2,3,5-triphenyltetrazolium chloride to 
determine the infarct size after MCAo. Eyes 
were also enucleated. Paraffin-embedded 
brain and retinal sections were prepared for 
TUNEL assay and immunohistochemistry. 
Protein lysate was collected for Western 
blotting experiments. Lutein's effect on Müller 
cells was further evaluated using a model of 
cobalt chloride-induced hypoxia in 
immortalized rat Müller cells (rMC-1).  
 
Results: Higher survival rate, better 
neurological scores, smaller infarct area and 
smaller infarct volume were noted in the lutein-
treated group. Immunohistochemistry data 
showed a decrease of immunoreactivity of 
nitrotyrosine, poly(ADP-ribose) and NFkB in 
the lutein-treated brains. Western blotting data 
showed decreased levels of Cox-2, pERK, and 
pIkB, but increased levels of Bcl-2, heat shock 
protein 70 and pAkt in the lutein-treated 
brains. In the retina, severe cell loss in retinal 
ganglion cell (RGC) layer was noted after I/R 
injury. Increased oxidative stress was 
observed in the injured retina. Lutein treatment 
protected RGC as well as decreased oxidative 
stress in I/R retina. Lutein treatment also 
minimized the deterioration of b-wave/a-wave 
ratio and oscillatory potentials in flash ERG as 
well as inhibited the up-regulation of GFAP in 
retinal I/R injury. In the cultured Müller cells, 
lutein treatment reduced level of nuclear NF-
kB together with decreased levels of IL-1b and 
Cox-2. 
 
Conclusions: Post-treatment of lutein 
protected both the brain and retina from I/R 
injury. The neuroprotective effect of lutein was 
associated with reduced oxidative stress. Less 
production of pro-inflammatory factors from 
Müller cells suggested an anti-inflammatory 
role of lutein in retinal ischemic/hypoxic injury. 
Our results suggest that lutein could diminish 
the deleterious outcomes of cerebral and 
retinal I/R probably by its anti-apoptotic, anti-
oxidative and anti-inflammatory properties. 
Lutein may have a therapeutic role in 
protecting the brain in stroke and inner retina 
in eye diseases with acute ischemia. 
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Background and purpose: Neuroprotective 
effects of hypoxic preconditioning have been 
demonstrated in the transient focal ischemia-
reperfusion injury. This study aims to verify the 
ameliorated effect of repetitive normobaric 
